Armata Pharmaceuticals Inc Sustainability Reports
A clinical-stage biotechnology company focused on the development of pathogen-specific bacteriophage therapeutics for antibiotic-resistant infections.
Sector: Manufacturing
Country: United States
Exchange: NYSE American
LEI: 549300QM1VCWH8KT0S21
FIGI: BBG001S5WNR0
4 reports from 2019 to 2024
